Article
Personalized treatment strategies in glioblastoma: MGMT promoter methylation status
1 Sept 2013
Abstract excerpt
The identification of molecular genetic biomarkers considerably increased our current understanding of glioma genesis, prognostic evaluation, and treatment planning. In glioblastoma, the most malignant intrinsic brain tumor entity in adults, the promoter methylation status of the gene encoding for the repair enzyme O6-methylguanine-DNA methyltransferase (MGMT) indicates increased efficacy of current standard of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
